Organic Letters
Letter
In summary, we have demonstrated a facile procedure
starting from azobenzenes and nitrosobenzenes to access
phenazine analogues. This procedure allowed the rapid access
of a series polysubstituted phenazine. Preliminary mechanistic
studies indicated that a sequential chelation-assisted addition
of aryl C−H to nitrosobenzenes and the ring closure by
electrophilic attack of azo group to aryl and aromatization
process was involved.
Scheme 3. Tentative Mechanism
ASSOCIATED CONTENT
* Supporting Information
■
S
The Supporting Information is available free of charge on the
Experimental procedures along with copies of spectra
AUTHOR INFORMATION
■
provided the corresponding products in relatively low yields
(3ba, 45%; 3ha, 37%). Meanwhile, this procedure was also
applicable for multisubstituted azobenzenes (3ia, 58%).
Disappointingly, the ortho-substituted analogues (3ka and
3la) did not work under the reaction conditions.
Corresponding Author
ORCID
Next, the substrate scope of nitrosobenzenes 2 was
investigated by the reaction of substituted nitrosobenzenes
with 1j (Figure 2). Various nitrosobenzenes 2 including those
bearing both electron-donating (methyl, tert-butyl and
methoxy) and electron-withdrawing groups (chloro, bromo)
were all well tolerated, affording the corresponding products
3ja−ji with yields ranging from 53% to 79%. Notably, some
nitrosobenzenes with electron-withdrawing groups such as
bromo (3jd, 79%) and chloro (3je, 75%) at the para-position
proceeded in good yields, while those with methyl (3jb, 69%)
and tert-butyl (3jc, 67%) provided the products in relatively
low yields. Typically, the compatibility of halogen-containing
substrates provided facile handles for potentially further
functionalizations. Moreover, multisubstituted nitrosobenzenes
also access phenazine analogues (3jf, 65%). In the cases of
meta-substituted nitrosobenzenes, 3jg and 3ji were isolated in
moderate yields (53−69%). Disappointingly, the ortho-
substituted analogues (3jj and 3jk) failed to work under the
reaction conditions.
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We thank the National Natural Science Foundation of China
(Nos. 21572025, 21602019, and 21672028), “Innovation &
Entrepreneurship Talents” Introduction Plan of Jiangsu
Province, Natural Science Foundation of Jiangsu Province
(BK20171193), the Key University Science Research Project
of Jiangsu Province (15KJA150001), Jiangsu Key Laboratory
of Advanced Catalytic Materials & Technology (BM2012110),
and Advanced Catalysis and Green Manufacturing Collabo-
rative Innovation Center for financial support. S.S. thanks the
Young Natural Science Foundation of Jiangsu Province
(BK20150263) for financial support.
The test of KIE on azobenzenes was failed since the H/D
exchange of azobenzenes was confirmed (Scheme 2, eqs 1).
This result indicated the cleavage of ortho-C−H in
azobenzenes was reversible. Meanwhile, the inter- and
intramolecular KIE for nitrosobenzene were both found to
be 1.5 (Scheme 2, eqs 2 and 3). Thus, the cleavage of the C−H
bond in nitrosobenzene was unlikely to be the rate-
determining step during this transformation.
A proposed mechanism is outlined in Scheme 3. First,
azobenzene undergoes directed ortho C−H bond cleavage
leading to metallacycle B. Then, the coordination and
migratory insertion of newly formed Rh−C bond into the
NO group takes place to form rhodacycle C. Second, the
protonolysis of rhodacycle C produces hydroxylamine D, along
with the regeneration of Rh(III) species to enter the catalytic
cycle. Third, intermediate F is formed via the sequential
alkylation of D by DCE and release of chloroethanal.15 Finally,
in the presence of proton, the intramolecular electrophilic
aromatic substitution of F forms G, which encounters the
aromatization leading to phenazine 3aa and aniline.
REFERENCES
■
(1) For reviews, see: (a) Guttenberger, N.; Blankenfeldt, W.;
Breinbauer, R. Bioorg. Med. Chem. 2017, 25, 6149. (b) Cimmino, A.;
Evidente, A.; Mathieu, V.; Andolfi, A.; Lefranc, F.; Kornienko, A.;
Kiss, R. Nat. Prod. Rep. 2012, 29, 487. (c) Guttenberger, N.;
Blankenfeldt, W.; Breinbauer, R. Bioorg. Med. Chem. 2017, 25, 6149.
(d) Laursen, J. B.; Nielsen, J. Chem. Rev. 2004, 104, 1663.
(2) (a) Laborda, P.; Zhao, Y.; Ling, J.; Hou, Ro.; Liu, F. J. Agric.
Food Chem. 2018, 66, 630. (b) Krishnaiah, M.; Rodrigues de Almeida,
N.; Udumula, V.; Song, Z.; Chhonker, Y. S.; Abdelmoaty, M. M.;
Aragao do Nascimento, V.; Murry, D. J.; Conda-Sheridan, M. Eur. J.
Med. Chem. 2018, 143, 936. (c) Udumula, V.; Endres, J. L.; Harper, C.
N.; Jaramillo, L.; Zhong, H. A.; Bayles, K. W.; Conda-Sheridan, M.
Eur. J. Med. Chem. 2017, 125, 710.
(3) (a) Niu, J.; Chen, J.; Xu, Z.; Zhu, X.; Wu, Q.; Li, J. Bioorg. Med.
Chem. Lett. 2016, 26, 5384. (b) Rusman, Y.; Oppegard, L. M.; Hiasa,
H.; Gelbmann, C.; Salomon, C. E. J. Nat. Prod. 2013, 76, 91.
(4) (a) Rinehart, K. L., Jr.; McMillan, M. W.; Witty, T. R.; Tipton,
C. D.; Shield, L. S.; Li, L. H.; Reusser, F. Bioorg. Chem. 1977, 6, 353.
(b) Wang, W.; Preville, P.; Morin, N.; Mounir, S.; Cai, W.; Siddiqui,
M. A. Bioorg. Med. Chem. Lett. 2000, 10, 1151.
C
Org. Lett. XXXX, XXX, XXX−XXX